Riemann a/s   Report issue

For profit Phase 3
Founded: Hillerod Denmark (1979)
Status: Left NME R&D (2009)

Organization Overview

First Clinical Trial
1998
NCT02500524
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1999

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

cocamide diethanolamine (2 trials)

permethrin (nix) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lice Infestations (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2